The advancement of modern medicine heavily relies on the precise synthesis of chiral molecules, where specific stereoisomers of a drug can dramatically influence its therapeutic effect and safety profile. DL-2-(2-Chlorophenyl)glycine, with its CAS number 141196-64-7, plays a pivotal role in this domain as a crucial chiral building block. NINGBO INNO PHARMCHEM CO.,LTD., a dedicated pharmaceutical intermediate manufacturer in China, provides this compound with the high purity and consistency essential for such sensitive applications.

As a racemic compound, DL-2-(2-Chlorophenyl)glycine contains both D and L enantiomers. This characteristic makes it an ideal starting material for chiral resolution, a process aimed at separating these enantiomers to isolate the biologically active form. This is particularly vital in the pharmaceutical industry, where often only one enantiomer possesses the desired pharmacological activity, while the other may be inactive or even detrimental.

The ability to efficiently resolve DL-2-(2-Chlorophenyl)glycine allows for the production of enantiomerically pure intermediates, which are then incorporated into the synthesis of complex Active Pharmaceutical Ingredients (APIs). This precision is key to developing targeted therapies that maximize efficacy and minimize side effects. Pharmaceutical companies depend on the availability of high-quality, reliably sourced chiral intermediates like DL-2-(2-Chlorophenyl)glycine to streamline their drug development pipelines.

NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of chiral intermediates. Our production processes are designed to ensure that our DL-2-(2-Chlorophenyl)glycine meets rigorous quality specifications, including chiral purity. We are committed to being a dependable partner for researchers and manufacturers seeking to advance their work in chiral API development. Choosing a trusted supplier in China like us means gaining access to high-quality materials and the expertise to support your complex synthetic needs.